GD-11 for Injection in the Treatment of Acute Ischemic Stroke

Clinical trial NCT06299579 · UNKNOWN

Trial details

NCT number: NCT06299579
Sponsor: Beijing Tiantan Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2024-02-29
Primary completion: 2025-02-22
Enrollment: 980

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.